Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
This randomized phase II trial studies how well erlotinib hydrochloride works in treating patients with bladder cancer undergoing surgery. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Inclusion criteria
- Bladder Carcinoma,Recurrent Bladder Carcinoma